Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developments in cardiac transplantation

S J Nisco1, B A Reitz

  • 1Stanford University School of Medicine, Department of Cardiothoracic Surgery, CA 94305.

Current Opinion in Cardiology
|March 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to letter regarding article entitled "Heart and combined heart–kidney transplantation in patients with concomitant renal insufficiency and end-stage heart failure".

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Combined heart-liver transplantation in the MELD era: do waitlisted patients require exception status?

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Heart and combined heart-kidney transplantation in patients with concomitant renal insufficiency and end-stage heart failure.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Same author

Twenty-year survivors of heart transplantation at Stanford University.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2008
Same author

Rabbit antithymocyte globulin versus OKT3 induction therapy after heart-lung and lung transplantation: effect on survival, rejection, infection, and obliterative bronchiolitis.

Transplant international : official journal of the European Society for Organ Transplantation·2001
Same author

Treatment of endocarditis with valve replacement: the question of tissue versus mechanical prosthesis.

The Annals of thoracic surgery·2001
Same journal

An integrative approach to patient selection for mitral transcatheter edge-to-edge repair in secondary mitral regurgitation.

Current opinion in cardiology·2026
Same journal

Rebooting blood vessel repair: implications of the SEMA-VR CardioLink-15 trial.

Current opinion in cardiology·2026
Same journal

Advancements in wearable technology for heart failure patients.

Current opinion in cardiology·2026
Same journal

Minimally invasive approaches to coronary artery bypass grafting: techniques, current evidence, and future directions.

Current opinion in cardiology·2026
Same journal

Advances in artificial intelligence for the evaluation of mitral regurgitation.

Current opinion in cardiology·2026
Same journal

Role of nutritional interventions to reduce cardiometabolic disease burden in the community.

Current opinion in cardiology·2026
See all related articles

Cardiac transplantation offers definitive treatment for end-stage heart disease, but donor organ shortages limit access. Recent advances focus on expanding the donor pool and improving management of vascular rejection, a persistent challenge in heart transplant recipients.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Immunology

Background:

  • Cardiac transplantation is a life-saving treatment for end-stage heart disease in adults and children.
  • A significant shortage of donor organs restricts access to this definitive therapy.
  • Current immunosuppression effectively manages cellular rejection but struggles with vascular rejection.

Purpose of the Study:

  • To review recent advances in cardiac transplantation, focusing on donor pool expansion and rejection management.
  • To highlight the urgent need for improved strategies to address vascular rejection in heart transplant recipients.

Main Methods:

  • Literature review of recent advancements in cardiac transplantation.
  • Analysis of current challenges in donor organ availability and immunosuppressive therapy.

Related Experiment Videos

  • Focus on strategies for managing acute and chronic vascular rejection.

    • Main Results:

    • Significant progress has been made in expanding the donor pool for cardiac transplantation.
    • Management of acute cellular rejection is successful with current immunosuppressive regimens.
    • Acute and chronic vascular rejection remain significant challenges in heart transplantation.

    Conclusions:

    • Expanding the donor pool is crucial for increasing access to cardiac transplantation.
    • Further research and clinical advancements are urgently needed to overcome the challenges of vascular rejection.
    • Improved management of vascular rejection is essential for better outcomes in heart transplant recipients.